The ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer.

NCT06068023 · clinicaltrials.gov ↗

RECRUITING

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Ampullary Adenocarcinoma

Interventions

DRUG: Folfirinox
DRUG: Capox

Sponsor

Fondazione Poliambulanza Istituto Ospedaliero

Collaborators

[object Object]